Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEHZB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,980
Award facts
- Contract value 100% obligated
- $1,980.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,980.48 by the Defense Logistics Agency on November 13, 2025. This delivery order represents a firm fixed-price contract with no set-aside designation, issued under the broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The company will provide pharmaceutical products and medical consumables to support Department of Defense healthcare operations, with the place of performance located in Park Ridge, Illinois, and an ultimate completion date of November 14, 2025.
This delivery order is part of DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract under the PPV-G GEN V program, which carries a ceiling value of $499.999 billion and extends through December 31, 2036. The underlying indefinite delivery contract, awarded on the same date, encompasses a 30-month base period with three 30-month option periods, positioning DMS Pharmaceutical Group as a regional prime vendor contractor within the $30.3 billion PPV-G GEN V acquisition strategy. The company's comprehensive product portfolio includes branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals such as oncology treatments, immunosuppressants, and emergency medications, enabling DLA to issue delivery orders for recurring medical supply needs across military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DU26FEHZB?
SPE2DU26FEHZB was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DU26FEHZB worth?
The government has obligated $1,980 on SPE2DU26FEHZB.
Is contract SPE2DU26FEHZB an order under another contract?
Yes. SPE2DU26FEHZB is a delivery order under SPE2DU25D9415, an indefinite delivery contract.
Was contract SPE2DU26FEHZB competed?
The extent of competition for SPE2DU26FEHZB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award